Integer (ITGR) Stock Forecast, Price Target & Predictions
ITGR Stock Forecast
Integer stock forecast is as follows: an average price target of $138.00 (represents a 3.47% upside from ITGR’s last price of $133.37) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
ITGR Price Target
ITGR Analyst Ratings
Buy
Integer Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 15, 2024 | Brett Fishbin | KeyBanc | $144.00 | $132.59 | 8.61% | 7.97% |
Oct 01, 2024 | Richard Newitter | Truist Financial | $145.00 | $128.97 | 12.43% | 8.72% |
May 15, 2024 | Richard Newitter | Truist Financial | $137.00 | $112.01 | 22.31% | 2.72% |
Apr 29, 2024 | Jasper Hellweg | Argus Research | $125.00 | $112.84 | 10.78% | -6.28% |
10
Integer Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 2 | 4 |
Avg Price Target | - | $144.50 | $137.75 |
Last Closing Price | $133.37 | $133.37 | $133.37 |
Upside/Downside | -100.00% | 8.35% | 3.28% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 21, 2024 | Truist Financial | Buy | Buy | Hold |
Oct 21, 2024 | Benchmark | Buy | Buy | Hold |
Oct 15, 2024 | KeyBanc | Overweight | Overweight | Hold |
Oct 02, 2024 | Oppenheimer | Buy | Buy | Hold |
Oct 02, 2024 | Citigroup | Underperform | Underperform | Hold |
Jul 16, 2024 | Oppenheimer | Buy | Buy | Hold |
Jul 16, 2024 | Citigroup | Underperform | Underperform | Hold |
Jul 15, 2024 | Oppenheimer | - | Outperform | Initialise |
May 22, 2024 | Citigroup | Neutral | Neutral | Hold |
May 15, 2024 | Benchmark | Buy | Buy | Hold |
10
Integer Financial Forecast
Integer Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | $404.69M | $694.28M | $378.79M | $372.42M | $342.68M | $350.08M | $310.91M | $313.01M | $305.57M | $312.02M | $290.47M | $268.96M | $235.94M | $240.12M | $328.43M | $325.64M | $303.59M | $314.19M | $314.68M | $381.75M | $345.41M |
Avg Forecast | $480.04M | $465.87M | $460.65M | $437.49M | $447.01M | $440.59M | $437.00M | $412.78M | $407.69M | $376.70M | $366.99M | $352.43M | $361.25M | $342.80M | $343.57M | $314.57M | $307.70M | $303.23M | $294.17M | $284.20M | $263.77M | $235.23M | $241.90M | $298.90M | $321.33M | $312.15M | $317.93M | $301.84M | $335.54M | $383.79M |
High Forecast | $486.91M | $472.54M | $467.24M | $442.44M | $457.22M | $442.11M | $437.00M | $412.78M | $407.73M | $381.49M | $372.24M | $357.47M | $366.42M | $342.80M | $343.57M | $314.57M | $307.70M | $303.23M | $294.17M | $284.20M | $263.77M | $235.23M | $241.90M | $298.90M | $321.33M | $312.15M | $317.93M | $301.84M | $402.65M | $460.55M |
Low Forecast | $472.86M | $458.90M | $453.76M | $434.46M | $436.78M | $439.07M | $437.00M | $412.78M | $407.64M | $372.27M | $361.50M | $347.16M | $355.85M | $342.80M | $343.57M | $314.57M | $307.70M | $303.23M | $294.17M | $284.20M | $263.77M | $235.23M | $241.90M | $298.90M | $321.33M | $312.15M | $317.93M | $301.84M | $268.43M | $307.03M |
# Analysts | 1 | 1 | 1 | 4 | 6 | 4 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 7 | 5 | 3 | 3 | 5 | 9 | 9 |
Surprise % | - | - | - | - | - | - | - | - | - | 1.07% | 1.89% | 1.07% | 1.03% | 1.00% | 1.02% | 0.99% | 1.02% | 1.01% | 1.06% | 1.02% | 1.02% | 1.00% | 0.99% | 1.10% | 1.01% | 0.97% | 0.99% | 1.04% | 1.14% | 0.90% |
Forecast
Integer EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 4 | 6 | 4 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 7 | 5 | 3 | 3 | 5 | 9 | 9 |
EBITDA | - | - | - | - | - | - | - | - | - | $69.40M | $41.58M | $58.91M | $40.98M | $53.08M | $59.05M | $45.50M | $52.32M | $53.29M | $58.44M | $53.80M | $47.54M | $60.70M | $29.02M | $66.49M | $42.97M | $66.70M | $72.16M | $58.92M | $64.99M | $49.30M |
Avg Forecast | $86.36M | $83.82M | $82.88M | $78.71M | $80.42M | $79.27M | $78.62M | $72.64M | $73.35M | $67.77M | $66.02M | $66.04M | $55.75M | $60.43M | $60.56M | $60.03M | $50.68M | $53.45M | $51.85M | $50.10M | $46.50M | $41.47M | $42.64M | $54.58M | $56.64M | $55.02M | $56.04M | $45.10M | $74.80M | $64.35M |
High Forecast | $87.60M | $85.02M | $84.06M | $79.60M | $82.26M | $79.54M | $78.62M | $87.17M | $73.35M | $68.63M | $66.97M | $79.24M | $66.90M | $60.43M | $60.56M | $72.04M | $60.82M | $53.45M | $51.85M | $50.10M | $46.50M | $41.47M | $42.64M | $65.49M | $56.64M | $55.02M | $56.04M | $54.12M | $89.76M | $77.22M |
Low Forecast | $85.07M | $82.56M | $81.64M | $78.16M | $78.58M | $78.99M | $78.62M | $58.11M | $73.34M | $66.98M | $65.04M | $52.83M | $44.60M | $60.43M | $60.56M | $48.03M | $40.55M | $53.45M | $51.85M | $50.10M | $46.50M | $41.47M | $42.64M | $43.66M | $56.64M | $55.02M | $56.04M | $36.08M | $59.84M | $51.48M |
Surprise % | - | - | - | - | - | - | - | - | - | 1.02% | 0.63% | 0.89% | 0.74% | 0.88% | 0.98% | 0.76% | 1.03% | 1.00% | 1.13% | 1.07% | 1.02% | 1.46% | 0.68% | 1.22% | 0.76% | 1.21% | 1.29% | 1.31% | 0.87% | 0.77% |
Forecast
Integer Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 4 | 6 | 4 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 7 | 5 | 3 | 3 | 5 | 9 | 9 |
Net Income | - | - | - | - | - | - | - | - | - | $27.26M | $23.97M | $13.06M | $18.12M | $16.06M | $20.84M | $11.37M | $20.00M | $22.07M | $29.43M | $21.52M | $15.43M | $30.34M | $389.00K | $31.10M | $11.02M | $30.59M | $33.06M | $21.67M | $8.12M | $-4.34M |
Avg Forecast | $59.89M | $55.22M | $53.25M | $48.17M | $52.26M | $48.73M | $43.95M | $33.97M | $47.70M | $39.32M | $35.81M | $30.89M | $25.35M | $26.29M | $40.50M | $28.08M | $23.05M | $29.73M | $28.90M | $25.82M | $18.12M | $9.47M | $7.46M | $25.53M | $37.31M | $34.02M | $34.55M | $16.59M | $9.14M | $-5.66M |
High Forecast | $61.00M | $56.25M | $54.24M | $48.90M | $52.98M | $48.94M | $46.01M | $40.77M | $49.13M | $41.47M | $36.48M | $37.06M | $30.42M | $26.29M | $40.76M | $33.69M | $27.65M | $29.73M | $28.90M | $25.82M | $18.12M | $9.47M | $7.46M | $30.63M | $37.31M | $34.02M | $34.55M | $19.90M | $10.97M | $-4.53M |
Low Forecast | $58.73M | $54.15M | $52.21M | $47.44M | $51.90M | $48.53M | $41.90M | $27.18M | $46.28M | $36.46M | $35.12M | $24.71M | $20.28M | $26.29M | $40.24M | $22.46M | $18.44M | $29.73M | $28.90M | $25.82M | $18.12M | $9.47M | $7.46M | $20.42M | $37.31M | $34.02M | $34.55M | $13.27M | $7.31M | $-6.80M |
Surprise % | - | - | - | - | - | - | - | - | - | 0.69% | 0.67% | 0.42% | 0.71% | 0.61% | 0.51% | 0.40% | 0.87% | 0.74% | 1.02% | 0.83% | 0.85% | 3.20% | 0.05% | 1.22% | 0.30% | 0.90% | 0.96% | 1.31% | 0.89% | 0.77% |
Forecast
Integer SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 4 | 6 | 4 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 7 | 5 | 3 | 3 | 5 | 9 | 9 |
SG&A | - | - | - | - | - | - | - | - | - | $42.10M | $45.83M | $41.89M | $41.04M | $38.20M | $41.79M | $39.56M | $36.27M | $34.27M | $35.38M | $35.50M | $35.04M | $3.61M | $33.90M | $36.46M | $37.66M | $32.94M | $33.14M | $34.96M | $41.24M | $39.50M |
Avg Forecast | $53.22M | $51.65M | $51.07M | $48.50M | $49.55M | $48.84M | $48.44M | $43.03M | $45.19M | $41.76M | $40.68M | $39.11M | $38.65M | $38.00M | $38.09M | $35.56M | $35.13M | $33.62M | $32.61M | $31.51M | $29.24M | $26.08M | $26.82M | $32.33M | $35.62M | $34.60M | $35.25M | $28.72M | $45.48M | $51.55M |
High Forecast | $53.98M | $52.38M | $51.80M | $49.05M | $50.69M | $49.01M | $48.44M | $51.63M | $45.20M | $42.29M | $41.27M | $46.94M | $46.38M | $38.00M | $38.09M | $42.67M | $42.16M | $33.62M | $32.61M | $31.51M | $29.24M | $26.08M | $26.82M | $38.79M | $35.62M | $34.60M | $35.25M | $34.46M | $54.58M | $61.86M |
Low Forecast | $52.42M | $50.87M | $50.30M | $48.16M | $48.42M | $48.67M | $48.44M | $34.42M | $45.19M | $41.27M | $40.07M | $31.29M | $30.92M | $38.00M | $38.09M | $28.45M | $28.11M | $33.62M | $32.61M | $31.51M | $29.24M | $26.08M | $26.82M | $25.86M | $35.62M | $34.60M | $35.25M | $22.98M | $36.39M | $41.24M |
Surprise % | - | - | - | - | - | - | - | - | - | 1.01% | 1.13% | 1.07% | 1.06% | 1.01% | 1.10% | 1.11% | 1.03% | 1.02% | 1.08% | 1.13% | 1.20% | 0.14% | 1.26% | 1.13% | 1.06% | 0.95% | 0.94% | 1.22% | 0.91% | 0.77% |
Forecast
Integer EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 4 | 6 | 4 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 7 | 5 | 3 | 3 | 5 | 9 | 9 |
EPS | - | - | - | - | - | - | - | - | - | $0.82 | $0.72 | $0.39 | $0.55 | $0.48 | $0.63 | $0.34 | $0.61 | $0.67 | $0.89 | $0.65 | $0.47 | $0.92 | $0.01 | $0.95 | $0.34 | $0.94 | $1.01 | $0.67 | $0.25 | $-0.14 |
Avg Forecast | $1.67 | $1.54 | $1.49 | $1.35 | $1.46 | $1.36 | $1.23 | $1.11 | $1.33 | $1.10 | $1.00 | $0.83 | $1.06 | $0.74 | $1.14 | $0.85 | $0.86 | $0.84 | $0.81 | $0.73 | $0.51 | $0.27 | $0.21 | $0.85 | $1.05 | $0.96 | $0.97 | $0.76 | $0.79 | $0.77 |
High Forecast | $1.70 | $1.57 | $1.52 | $1.37 | $1.48 | $1.37 | $1.29 | $1.11 | $1.37 | $1.16 | $1.02 | $0.85 | $1.08 | $0.74 | $1.15 | $0.85 | $0.86 | $0.84 | $0.81 | $0.73 | $0.51 | $0.27 | $0.21 | $0.85 | $1.05 | $0.96 | $0.97 | $0.76 | $0.95 | $0.92 |
Low Forecast | $1.64 | $1.51 | $1.46 | $1.33 | $1.45 | $1.36 | $1.17 | $1.11 | $1.29 | $1.02 | $0.98 | $0.82 | $1.04 | $0.74 | $1.13 | $0.85 | $0.86 | $0.84 | $0.81 | $0.73 | $0.51 | $0.27 | $0.21 | $0.85 | $1.05 | $0.96 | $0.97 | $0.76 | $0.63 | $0.62 |
Surprise % | - | - | - | - | - | - | - | - | - | 0.75% | 0.72% | 0.47% | 0.52% | 0.65% | 0.55% | 0.40% | 0.71% | 0.80% | 1.09% | 0.89% | 0.92% | 3.45% | 0.05% | 1.11% | 0.32% | 0.98% | 1.04% | 0.88% | 0.32% | -0.18% |
Forecast
Integer Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
NVRO | Nevro | $4.23 | $32.72 | 673.52% | Hold |
LUNG | Pulmonx | $6.20 | $11.93 | 92.42% | Buy |
ESTA | Establishment Labs | $41.81 | $78.00 | 86.56% | Buy |
IRTC | iRhythm | $73.74 | $121.17 | 64.32% | Buy |
KIDS | OrthoPediatrics | $25.50 | $39.60 | 55.29% | Buy |
LIVN | LivaNova | $50.05 | $70.50 | 40.86% | Buy |
NPCE | NeuroPace | $9.19 | $12.88 | 40.15% | Buy |
BRKR | Bruker | $53.37 | $73.75 | 38.19% | Buy |
CNMD | CONMED | $70.69 | $96.00 | 35.80% | Buy |
OFIX | Orthofix Medical | $18.87 | $24.00 | 27.19% | - |
IRMD | IRadimed | $52.08 | $60.00 | 15.21% | Buy |
ITGR | Integer | $133.37 | $138.00 | 3.47% | Buy |
GKOS | Glaukos | $141.44 | $123.44 | -12.73% | Buy |